HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK, Tereza VRBOVÁ, Miloslav KLUGAR and Jitka KLUGAROVÁ. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project. JBI EVIDENCE IMPLEMENTATION. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 21, S1, p. "S57"-"S63", 7 pp. ISSN 2691-3321. Available from: https://dx.doi.org/10.1097/XEB.0000000000000400.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project
Authors HAJEK, Michal (203 Czech Republic), Dittmar CHMELAR (203 Czech Republic), Miroslav ROZLOZNIK (203 Czech Republic), Alexandra LOCHMANOVA (203 Czech Republic), Jakub TLAPAK (203 Czech Republic), Tereza VRBOVÁ (203 Czech Republic, belonging to the institution), Miloslav KLUGAR (203 Czech Republic, belonging to the institution) and Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution).
Edition JBI EVIDENCE IMPLEMENTATION, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2691-3321.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.300 in 2022
RIV identification code RIV/00216224:14110/23:00133702
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/XEB.0000000000000400
UT WoS 001111566500002
Keywords in English COVID-19; health care professionals; hyperbaric oxygen therapy; infection control
Tags 14119612, 14119613, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/2/2024 14:57.
Abstract
Objective:This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021).Introduction:This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital.Methods:Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits.Results:Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients.Conclusions:Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.
PrintDisplayed: 22/7/2024 15:25